Surrozen (SRZN) Change in Cash (2020 - 2026)
Surrozen (SRZN) posted quarterly Change in Cash of $17.7 million for Q1 2026, down 73.67% year-over-year from $67.1 million in Q1 2025, and up 123.32% quarter-over-quarter from $7.9 million in Q4 2025.
Surrozen (SRZN) Change in Cash (2020 - 2026) Analysis & Trends
Surrozen's Change in Cash history runs 7 years deep, the most recent figure standing at $17.7 million for Q1 2026.
- In Q1 2026, Change in Cash fell 73.67% year-over-year to $17.7 million; the TTM figure through Mar 2026 stood at $5.3 million (down 92.92% YoY), while the FY2025 annual figure was $54.7 million, up 3799.59% from the prior year.
- Change in Cash for Q1 2026 stood at $17.7 million, up from $7.9 million in the prior quarter.
- The five-year high for Change in Cash was $67.1 million in Q1 2025, with the low at -$18.8 million in Q1 2022.
- The 5-year median for Change in Cash is $2.6 million (2022), against an average of $4.4 million.
- The sharpest annual moves came in 2024 and 2025: Change in Cash tumbled 380.63% in 2024, then soared 866.37% in 2025.
- Surrozen's Change in Cash stood at -$841000.0 in 2022, then soared by 377.05% to $2.3 million in 2023, then surged by 52.49% to $3.6 million in 2024, then jumped by 122.63% to $7.9 million in 2025, then surged by 123.32% to $17.7 million in 2026.
- Business Quant data shows SRZN's Change in Cash at $17.7 million in Q1 2026, $7.9 million in Q4 2025, and -$9.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Surrozen | 281.63 Mn | 281.63 Mn | - | -4.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.92 Mn |
| Mar 31, 2026 | 17.67 Mn |
| Dec 31, 2025 | 7.91 Mn |
| Sep 30, 2025 | -9.06 Mn |
| Jun 30, 2025 | -11.26 Mn |
| Mar 31, 2025 | 67.08 Mn |
| Dec 31, 2024 | 3.55 Mn |
| Sep 30, 2024 | -6.75 Mn |
| Jun 30, 2024 | 10.48 Mn |
| Mar 31, 2024 | -8.75 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Sep 30, 2023 | -2.50 Mn |
| Jun 30, 2023 | 8.69 Mn |
| Mar 31, 2023 | 3.12 Mn |
| Dec 31, 2022 | -841,000.00 |
| Sep 30, 2022 | 8.67 Mn |
| Jun 30, 2022 | 2.56 Mn |
| Mar 31, 2022 | -18.79 Mn |
| Dec 31, 2021 | -28.01 Mn |
| Sep 30, 2021 | 42.25 Mn |